Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting

Abstract Objective Ondansetron orally soluble pellicle can serve as an alternative option for preventing nausea and vomiting in patients who receive chemotherapy. However, there is a lack of clinical evidence regarding ondansetron. This study aimed to explore the efficacy and safety of ondansetron i...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lu Sun, Jia Ma, Yajuan Zhou, Xiaofang Ying, Gai Liang, Guoliang Pi, Ying Li, Yan Luo, Jianping Bi, Hanping He, Yi Peng
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-01-01
Series:	BMC Cancer
Assuntos:	Ondansetron orally soluble pellicle Moderate-to-high emetic risk chemotherapy Nausea and vomiting Efficacy Safety
Acceso en liña:	https://doi.org/10.1186/s12885-024-13406-z
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!